NDC11 64764010710
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64764-0107-10 | 64764-0107 |
| 64764-107-10 | 64764-107 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ENTYVIO | VEDOLIZUMAB | Takeda Pharmaceuticals America, Inc. | 6e94621c-1a95-4af9-98d1-52b9e6f1949c | 2026-04-29 | Warnings, Adverse reactions | 64764-107-10 64764-107 64764010710 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.